![]() Massachusetts General Hospital - Internal Medicine.Lee Moffitt Cancer Center and Research Institute - Hematology/Oncology He completed an Internal Medicine Residency at Massachusetts General Hospital and, most recently, a Hematology/Oncology Fellowship at Moffitt Cancer Center. His research interests focus on the development of novel, targeted therapeutic strategies (Phase I and II clinical trials) for patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML), based on the underlying mutational drivers of each disease. ![]() Sallman earned his MD degree from the University of South Florida College of Medicine. Sallman’s clinical interests are myelodysplastic syndromes (MDS), acute myeloid leukemia (AML) and myeloproliferative neoplasms (MPN). David Sallman is an Assistant Member in the Department of Malignant Hematology at Moffitt Cancer Center. Leukemia, Myelodysplastic Syndromes (MDS)ĭr.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |